home / stock / achv / achv news

ACHV News and Press, Achieve Life Sciences Inc. From 10/31/19

Stock Information
Company Name: Achieve Life Sciences Inc.
Stock Symbol: ACHV
Market: NASDAQ
Website: achievelifesciences.com
Menu
ACHV ACHV Quote ACHV Short ACHV News ACHV Articles ACHV Message Board
Get ACHV Alerts

News, Short Squeeze, Breakout and More Instantly...
ACHV - Achieve Life Sciences to Announce Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 6, 2019

SEATTLE and VANCOUVER, British Columbia , Oct. 31, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotin...
ACHV - Achieve Life Sciences to launch late-stage development of cytisinicline in 2020

Achieve Life Sciences (NASDAQ: ACHV ) confirms that it will evaluate 3 mg of smoking cessation med cytisinicline dosed three times per day in its Phase 3 program that will launch in 2020 subject to sufficient capital. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, ...

ACHV - Achieve Life Sciences Announces Presentation of Cytisinicline Data at Society for Research on Nicotine & Tobacco Oceania (SRNT-O) Inaugural Conference

Achieve Life Sciences Announces Presentation of Cytisinicline Data at Society for Research on Nicotine & Tobacco Oceania (SRNT-O) Inaugural Conference Achieve Life Sciences Announces Presentation of Cytisinicline Data at Society for Research on Nicotine & Tobacco Oceania (S...

ACHV - Achieve Life Sciences Announces Completion of Maximum Tolerated Dose Study

Achieve Life Sciences Announces Completion of Maximum Tolerated Dose Study Canada NewsWire SEATTLE and VANCOUVER, British Columbia, Sept. 30, 2019 SEATTLE and VANCOUVER, British Columbia , Sept. 30, 2019 /CNW/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinic...
ACHV - Key events next week - healthcare

Noteworthy events during the week of September 15 - 21 for healthcare investors. More news on: CRISPR Therapeutics AG, Pluristem Therapeutics Inc., GlaxoSmithKline plc, Healthcare stocks news, , Read more ...

ACHV - Achieve Life Sciences Announces Final Phase 2b ORCA-1 Trial Data Presented at Society for Research on Nicotine & Tobacco Europe (SRNT-E) 19th Annual Conference

SEATTLE and VANCOUVER, British Columbia , Sept. 13, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that t...

ACHV - Achieve Life Sciences to Host Investor Day on September 20th Including Roundtable Discussion with Smoking Cessation Medical Experts and Final Data from the Phase 2b ORCA-1 Trial

SEATTLE and VANCOUVER, British Columbia , Sept. 5, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced the Company ...
ACHV - Achieve Life Sciences Announces Presentations at Upcoming Investor Conferences

Achieve Life Sciences Announces Presentations at Upcoming Investor Conferences Canada NewsWire SEATTLE and VANCOUVER, British Columbia, Sept. 4, 2019 SEATTLE and VANCOUVER, British Columbia , Sept. 4, 2019 /CNW/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clin...

ACHV - Achieve Life Sciences, Inc. (ACHV) CEO Rick Stewart on Q2 2019 Results - Earnings Call Transcript

Achieve Life Sciences, Inc. (ACHV) Q2 2019 Earnings Conference Call August 08, 2019, 16:30 ET Company Participants Jaime Xinos - EVP, Commercial Rick Stewart - Chairman and CEO John Bencich - Chief Financial and Operating Officer Cindy Jacobs - EVP and Chief Medical Officer ...

ACHV - Achieve Life Sciences EPS beats by $0.06

Achieve Life Sciences (NASDAQ: ACHV ): Q2 GAAP EPS of -$0.50 beats by $0.06 . More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

Previous 10 Next 10